The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab

首页> 外文期刊>Intelligence: A Multidisciplinary Journal >The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab

【24h】

The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab

机译：中性粒细胞对淋巴细胞比的预后和预测作用，紫杉醇 - Bevacizumab治疗Her2阴性转移性乳腺癌患者中的血小板到淋巴细胞比和淋巴细胞对单核细胞比例

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Intelligence: A Multidisciplinary Journal》 |2020年第2020期|共2页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心理学;
关键词

相似文献

外文文献
中文文献
专利

1. The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：中性粒细胞对淋巴细胞比的预后和预测作用，紫杉醇 - Bevacizumab治疗Her2阴性转移性乳腺癌患者中的血小板到淋巴细胞比和淋巴细胞对单核细胞比例
2. Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT) [J] . Hyder J., Jang H., Kim S., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：中性粒细胞对淋巴细胞比（NLR），血小板对淋巴细胞比（PLR）和淋巴细胞对单核细胞比（LMR）的预后值宫颈癌患者进行了明确的化学疗法（DCRT）
3. Prognostic value of neutrophil-to-lymphocyte, platelet-to-lymphocyte and lymphocyte-to-monocyte ratio ratios in patients operated on due to non-small cell lung cancer [J] . Mariusz ?ochowski, Barbara ?ochowska, Izabela Zawadzka, Journal of Thoracic Disease . 2019,第8期

机译：由于非小细胞肺癌，血小板到淋巴细胞，血小板到淋巴细胞和淋巴细胞对单核细胞比率比率的预后值
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. Utilities of metastatic breast cancer patients treated with taxanes compared to utilities of oncology nurses. [D] . Hauser, Robert Sean. 2001

机译：与肿瘤科护士相比，使用紫杉烷类治疗的转移性乳腺癌患者的效用。
6. The prognostic impact of neutrophil-to-lymphocyte ratio lymphocyte-to-monocyte ratio and platelet-to-lymphocyte ratio in patients with advanced colorectal cancer treated with first-line chemotherapy [O] . Magdalena Krakowska, Sylwia Dębska-Szmich, Rafał Czyżykowski, 2018

机译：一线化疗对晚期大肠癌患者中性粒细胞与淋巴细胞之比淋巴细胞与单核细胞之比以及血小板与淋巴细胞之比的预后影响
7. An Update on Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio (NLR), Platelet-To-Lymphocyte Ratio (PLR) and Lymphocyte-To-Monocyte Ratio (LMR) for Patients with Cervical Cancer Undergoing Definitive Chemoradiotherapy (dCRT) [O] . H. Trinh, H. Jang, S. Kim, 2020

机译：用于宫颈癌患者的中性粒细胞对淋巴细胞比（NLR），血小板到淋巴细胞比（PLR）和淋巴细胞对单核细胞比（LMR）的预后值的更新宫颈癌患者进行了明确的化学疗法（DCRT）

The prognostic and predictive roles of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio in HER2-negative metastatic breast cancer patients treated with paclitaxel-bevacizumab

著录项

相似文献

相关主题

期刊订阅